Try our Advanced Search for more refined results

Celgene, Barr Resolve Spat Over Generic Thalomid

By Allison Grande (May 26, 2010, 7:34 PM EDT) -- Pharmaceutical company Celgene Corp. and generic-drug maker Barr Laboratories Inc. have resolved their dispute over generic competition for the cancer drug Thalomid, with Celgene agreeing to drop its patent infringement claims and Barr shedding its invalidity and antitrust allegations....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Judge Analytics

powered by Lex Machina®

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!